HUNTINGDON VALLEY, Pa., Sept. 27 /PRNewswire-FirstCall/ -- Cellegy Pharmaceuticals, Inc. Richard C. Williams, Cellegy's Chairman and Interim CEO, is scheduled to speak on Wednesday, September 27, 2006 at 12:00 p.m. (Eastern).
To participate in the live conference, dial in information is as follows:
Domestic US Dial In: 800-706-7749
International Dial In: 617-614-3474
Participant Pass Code: 10479330
To replay a recording of the conference after 2:00 p.m., September 27, 2006 up to ten days subsequent to the live conference, dial in information is as follows:
Domestic US Dial In: 888-286-8010
International Dial In: 617-801-6888
Participant Pass Code: 90368159
To participate in the Weblink live conference:
Cellegy Pharmaceuticals is a specialty biopharmaceutical company that develops and commercializes prescription drugs for the treatment of women's health care conditions, including sexual dysfunction, HIV prevention; and, gastrointestinal disorders. Savvy(R) (C31G vaginal gel), a novel microbicide gel product for contraception and the reduction in transmission of HIV in women, is currently undergoing Phase 3 clinical studies in the United States.
ProStrakan Group plc is an international specialty pharmaceutical company engaged in the research, development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets.
Cellegy Pharmaceuticals, Inc.
CONTACT: Richard C. Williams, Chairman and Interim CEO, +1-650-616-2200,or Robert J. Caso, Vice President, Finance & CFO, +1-215-914-0900, ext.603, for Cellegy Pharmaceuticals, Inc.